Abstract
Abnormal intrauterine growth and other adverse early-life exposures may induce adaptations that in turn predispose the individual to chronic diseases later in life. This type of adaptation may be marked by changes in systems, organs, and tissues. The immediate benefits of early plasticity or adaptability may come at a cost with repercussions, such as increased susceptibility to diabetes, cardiovascular and other age-related diseases, as well as cancer, manifesting in adulthood. Some fetal adaptations may not necessarily be apparent at birth, but may be revealed later in life when invoked by cumulative environmental challenges (e.g., high fat or westernized diet). Early life exposures may represent the advancement of the normal decline of resistance to disease that occurs with aging. Developmental origin of adult disease may be viewed in the same framework of other progressive disorders defined by increasing epigenetic dysregulation, such as cancer and as such may have identifiable biomarkers. Assays that measure epigenetic changes hold great promise as biomarkers for disease states in which risk can be attributable to gene–environment interactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Choudhury M, Friedman JE (2011) Obesity: childhood obesity—methylate now, pay later? Nat Rev Endocrinol 7(8):439–440
Wolffe AP, Guschin D (2000) Review: chromatin structural features and targets that regulate transcription. J Struct Biol 129(2-3):102–122
Kaminsky ZA, Tang T, Wang SC, Ptak C, Oh GH, Wong AH et al (2009) DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet 41(2):240–245
Saetrom P, Snove O Jr, Rossi JJ (2007) Epigenetics and microRNAs. Pediatr Res 61(5 Pt 2):17R–23R
Vargesson N (2015) Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today 105(2):140–156
Kowalski TW, Sanseverino MT, Schuler-Faccini L, Vianna FS (2015) Thalidomide embryopathy: follow-up of cases born between 1959 and 2010. Birth Defects Res A Clin Mol Teratol 103(9):794–803
Kelsey FO (1988) Thalidomide update: regulatory aspects. Teratology 38(3):221–226
Paulino AC, Constine LS, Rubin P, Williams JP (2010) Normal tissue development, homeostasis, senescence, and the sensitivity to radiation injury across the age spectrum. Semin Radiat Oncol 20(1):12–20
Ravelli GP, Stein ZA, Susser MW (1976) Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 295(7):349–353
Barker DJ, Osmond C (1986) Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1(8489):1077–1081
Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ (1989) Weight in infancy and death from ischaemic heart disease. Lancet 2(8663):577–580
Barker DJ, Osmond C, Law CM (1989) The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. J Epidemiol Community Health 43(3):237–240
Hales CN, Barker DJ (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35(7):595–601
Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303(6809):1019–1022
Painter RC, Roseboom TJ, Bleker OP (2005) Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 20(3):345–352
Roseboom TJ, van der Meulen JH, Ravelli AC, Osmond C, Barker DJ, Bleker OP (2001) Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview. Mol Cell Endocrinol 185(1-2):93–98
Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet 341(8850):938–941
Frankel S, Elwood P, Sweetnam P, Yarnell J, Smith GD (1996) Birthweight, body-mass index in middle age, and incident coronary heart disease. Lancet 348(9040):1478–1480
Leon DA, Lithell HO, Vagero D, Koupilova I, Mohsen R, Berglund L et al (1998) Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915–29. BMJ 317(7153):241–245
Stein CE, Fall CH, Kumaran K, Osmond C, Cox V, Barker DJ (1996) Fetal growth and coronary heart disease in south India. Lancet 348(9037):1269–1273
Rao KR, Padmavathi IJ, Raghunath M (2012) Maternal micronutrient restriction programs the body adiposity, adipocyte function and lipid metabolism in offspring: a review. Rev Endocr Metab Disord 13(2):103–108
Rogers I, Group E-BS (2003) The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life. Int J Obes Relat Metab Disord 27(7):755–777
Huxley RR, Shiell AW, Law CM (2000) The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J Hypertens 18(7):815–831
Rexrode KM, Hennekens CH, Willett WC, Colditz GA, Stampfer MJ, Rich-Edwards JW et al (1997) A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 277(19):1539–1545
Dennison EM, Arden NK, Keen RW, Syddall H, Day IN, Spector TD et al (2001) Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Paediatr Perinat Epidemiol 15(3):211–219
Gershon A, Sudheimer K, Tirouvanziam R, Williams LM, O’Hara R (2013) The long-term impact of early adversity on late-life psychiatric disorders. Curr Psychiatry Rep 15(4):352
Kristjanson LJ, Chalmers KI (1991) Preventive work with families: issues facing public health nurses. J Adv Nurs 16(2):147–153
Waterland RA, Jirtle RL (2004) Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20(1):63–68
Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL (2006) Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114(4):567–572
Lane RH, MacLennan NK, Hsu JL, Janke SM, Pham TD (2002) Increased hepatic peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a rat model of intrauterine growth retardation and subsequent insulin resistance. Endocrinology 143(7):2486–2490
Peterside IE, Selak MA, Simmons RA (2003) Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats. Am J Physiol Endocrinol Metab 285(6):E1258–E1266
Lane RH, Kelley DE, Ritov VH, Tsirka AE, Gruetzmacher EM (2001) Altered expression and function of mitochondrial beta-oxidation enzymes in juvenile intrauterine-growth-retarded rat skeletal muscle. Pediatr Res 50(1):83–90
Lane RH, Maclennan NK, Daood MJ, Hsu JL, Janke SM, Pham TD et al (2003) IUGR alters postnatal rat skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a fiber specific manner. Pediatr Res 53(6):994–1000
Ozanne SE, Olsen GS, Hansen LL, Tingey KJ, Nave BT, Wang CL et al (2003) Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle. J Endocrinol 177(2):235–241
Ozanne SE, Nicholas HC (2005) Poor fetal growth followed by rapid postnatal catch-up growth leads to premature death. Mech Ageing Dev 126(8):852–854
Delahaye F, Breton C, Risold PY, Enache M, Dutriez-Casteloot I, Laborie C et al (2008) Maternal perinatal undernutrition drastically reduces postnatal leptin surge and affects the development of arcuate nucleus proopiomelanocortin neurons in neonatal male rat pups. Endocrinology 149(2):470–475
Puglianiello A, Germani D, Cianfarani S (2009) Exposure to uteroplacental insufficiency reduces the expression of signal transducer and activator of transcription 3 and proopiomelanocortin in the hypothalamus of newborn rats. Pediatr Res 66(2):208–211
Begum G, Davies A, Stevens A, Oliver M, Jaquiery A, Challis J et al (2013) Maternal undernutrition programs tissue-specific epigenetic changes in the glucocorticoid receptor in adult offspring. Endocrinology 154(12):4560–4569
Chen M, Xiong F, Zhang L (2013) Promoter methylation of Egr-1 site contributes to fetal hypoxia-mediated PKCepsilon gene repression in the developing heart. Am J Physiol Regul Integr Comp Physiol 304(9):R683–R689
Vidal AC, Murphy SK, Murtha AP, Schildkraut JM, Soubry A, Huang Z et al (2013) Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond) 37(7):907–913
Kaati G, Bygren LO, Edvinsson S (2002) Cardiovascular and diabetes mortality determined by nutrition during parents’ and grandparents’ slow growth period. Eur J Hum Genet 10(11):682–688
Pembrey ME, Bygren LO, Kaati G, Edvinsson S, Northstone K, Sjostrom M et al (2006) Sex-specific, male-line transgenerational responses in humans. Eur J Hum Genet 14(2):159–166
Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES et al (2008) Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 105(44):17046–17049
Fryer AA, Nafee TM, Ismail KM, Carroll WD, Emes RD, Farrell WE (2009) LINE-1 DNA methylation is inversely correlated with cord plasma homocysteine in man: a preliminary study. Epigenetics 4(6):394–398
Fryer AA, Emes RD, Ismail KM, Haworth KE, Mein C, Carroll WD et al (2011) Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans. Epigenetics 6(1):86–94
Kile ML, Baccarelli A, Tarantini L, Hoffman E, Wright RO, Christiani DC (2010) Correlation of global and gene-specific DNA methylation in maternal-infant pairs. PLoS One 5(10):e13730
Einstein F, Thompson RF, Bhagat TD, Fazzari MJ, Verma A, Barzilai N et al (2010) Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS One 5(1):e8887
Heijmans BT, Kremer D, Tobi EW, Boomsma DI, Slagboom PE (2007) Heritable rather than age-related environmental and stochastic factors dominate variation in DNA methylation of the human IGF2/H19 locus. Hum Mol Genet 16(5):547–554
Boney CM, Verma A, Tucker R, Vohr BR (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115(3):e290–e296
Baker JL, Olsen LW, Sorensen TI (2008) Weight at birth and all-cause mortality in adulthood. Epidemiology 19(2):197–203
Williams L, Seki Y, Vuguin PM, Charron MJ (2014) Animal models of in utero exposure to a high fat diet: a review. Biochim Biophys Acta 1842(3):507–519
Dunn GA, Bale TL (2009) Maternal high-fat diet promotes body length increases and insulin insensitivity in second-generation mice. Endocrinology 150(11):4999–5009
Dunn GA, Bale TL (2011) Maternal high-fat diet effects on third-generation female body size via the paternal lineage. Endocrinology 152(6):2228–2236
Delahaye F, Wijetunga NA, Heo HJ, Tozour JN, Zhao YM, Greally JM et al (2014) Sexual dimorphism in epigenomic responses of stem cells to extreme fetal growth. Nat Commun 5:5187
Ornoy A (2011) Prenatal origin of obesity and their complications: gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia. Reprod Toxicol 32(2):205–212
Lisboa PC, de Oliveira E, de Moura EG (2012) Obesity and endocrine dysfunction programmed by maternal smoking in pregnancy and lactation. Front Physiol 3:437
Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C et al (2011) Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes 60(5):1528–1534
Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM (2010) Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology 151(10):4756–4764
Masuyama H, Hiramatsu Y (2012) Effects of a high-fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expression. Endocrinology 153(6):2823–2830
Vazeille E, Slimani L, Claustre A, Magne H, Labas R, Bechet D et al (2012) Curcumin treatment prevents increased proteasome and apoptosome activities in rat skeletal muscle during reloading and improves subsequent recovery. J Nutr Biochem 23(3):245–251
Kelsall CJ, Hoile SP, Irvine NA, Masoodi M, Torrens C, Lillycrop KA et al (2012) Vascular dysfunction induced in offspring by maternal dietary fat involves altered arterial polyunsaturated fatty acid biosynthesis. PLoS One 7(4):e34492
Yang QY, Liang JF, Rogers CJ, Zhao JX, Zhu MJ, Du M (2013) Maternal obesity induces epigenetic modifications to facilitate Zfp423 expression and enhance adipogenic differentiation in fetal mice. Diabetes 62(11):3727–3735
Newbold RR (2010) Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens) 9(3):206–217
Smink A, Ribas-Fito N, Garcia R, Torrent M, Mendez MA, Grimalt JO et al (2008) Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr 97(10):1465–1469
Janesick A, Blumberg B (2011) Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today 93(1):34–50
Karmaus W, Osuch JR, Eneli I, Mudd LM, Zhang J, Mikucki D et al (2009) Maternal levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and body mass index in adult female offspring. Occup Environ Med 66(3):143–149
Mumtaz MM, George JD, Gold KW, Cibulas W, DeRosa CT (1996) ATSDR evaluation of health effects of chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem. Toxicol Ind Health 12(6):742–971
Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, Barr D et al (2003) Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect 111(2):201–205
Perera FP, Rauh V, Whyatt RM, Tsai WY, Bernert JT, Tu YH et al (2004) Molecular evidence of an interaction between prenatal environmental exposures and birth outcomes in a multiethnic population. Environ Health Perspect 112(5):626–630
Irigaray P, Ogier V, Jacquenet S, Notet V, Sibille P, Mejean L et al (2006) Benzo[a]pyrene impairs beta-adrenergic stimulation of adipose tissue lipolysis and causes weight gain in mice. A novel molecular mechanism of toxicity for a common food pollutant. FEBS J 273(7):1362–1372
Perera F, Tang WY, Herbstman J, Tang D, Levin L, Miller R et al (2009) Relation of DNA methylation of 5′-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS One 4(2):e4488
Suter M, Abramovici A, Showalter L, Hu M, Shope CD, Varner M et al (2010) In utero tobacco exposure epigenetically modifies placental CYP1A1 expression. Metabolism 59(10):1481–1490
Lyte M, Bick PH (1986) Modulation of interleukin-1 production by macrophages following benzo(a)pyrene exposure. Int J Immunopharmacol 8(3):377–381
Vandebriel RJ, Meredith C, Scott MP, Roholl PJ, Van Loveren H (1998) Effects of in vivo exposure to bis(tri-n-butyltin)oxide, hexachlorobenzene, and benzo(a)pyrene on cytokine (receptor) mRNA levels in cultured rat splenocytes and on IL-2 receptor protein levels. Toxicol Appl Pharmacol 148(1):126–136
Pei XH, Nakanishi Y, Inoue H, Takayama K, Bai F, Hara N (2002) Polycyclic aromatic hydrocarbons induce IL-8 expression through nuclear factor kappaB activation in A549 cell line. Cytokine 19(5):236–241
Khalil A, Villard PH, Dao MA, Burcelin R, Champion S, Fouchier F et al (2010) Polycyclic aromatic hydrocarbons potentiate high-fat diet effects on intestinal inflammation. Toxicol Lett 196(3):161–167
Withey JR, Shedden J, Law FC, Abedini S (1993) Distribution of benzo[a]pyrene in pregnant rats following inhalation exposure and a comparison with similar data obtained with pyrene. J Appl Toxicol 13(3):193–202
Perera FP, Tang D, Tu YH, Cruz LA, Borjas M, Bernert T et al (2004) Biomarkers in maternal and newborn blood indicate heightened fetal susceptibility to procarcinogenic DNA damage. Environ Health Perspect 112(10):1133–1136
Rundle A, Hoepner L, Hassoun A, Oberfield S, Freyer G, Holmes D et al (2012) Association of childhood obesity with maternal exposure to ambient air polycyclic aromatic hydrocarbons during pregnancy. Am J Epidemiol 175(11):1163–1172
Tang D, Li TY, Liu JJ, Chen YH, Qu L, Perera F (2006) PAH-DNA adducts in cord blood and fetal and child development in a Chinese cohort. Environ Health Perspect 114(8):1297–1300
Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240(4854):889–895
Koch HM, Calafat AM (2009) Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci 364(1526):2063–2078
Jacobs S, Teixeira DS, Guilherme C, da Rocha CF, Aranda BC, Reis AR et al (2014) The impact of maternal consumption of cafeteria diet on reproductive function in the offspring. Physiol Behav 129:280–286
Li CC, Young PE, Maloney CA, Eaton SA, Cowley MJ, Buckland ME et al (2013) Maternal obesity and diabetes induces latent metabolic defects and widespread epigenetic changes in isogenic mice. Epigenetics 8(6):602–611
Barres R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K et al (2009) Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 10(3):189–198
Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD (2000) Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 279(1):E83–E87
Garofano A, Czernichow P, Breant B (1999) Effect of ageing on beta-cell mass and function in rats malnourished during the perinatal period. Diabetologia 42(6):711–718
Park JH, Stoffers DA, Nicholls RD, Simmons RA (2008) Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 118(6):2316–2324
Yang BT, Dayeh TA, Volkov PA, Kirkpatrick CL, Malmgren S, Jing X et al (2012) Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol Endocrinol 26(7):1203–1212
Dahri S, Snoeck A, Reusens-Billen B, Remacle C, Hoet JJ (1991) Islet function in offspring of mothers on low-protein diet during gestation. Diabetes 40(Suppl 2):115–120
Burns SP, Desai M, Cohen RD, Hales CN, Iles RA, Germain JP et al (1997) Gluconeogenesis, glucose handling, and structural changes in livers of the adult offspring of rats partially deprived of protein during pregnancy and lactation. J Clin Invest 100(7):1768–1774
Ozanne SE, Wang CL, Coleman N, Smith GD (1996) Altered muscle insulin sensitivity in the male offspring of protein-malnourished rats. Am J Physiol 271(6 Pt 1):E1128–E1134
Ozanne SE, Dorling MW, Wang CL, Petry CJ (2000) Depot-specific effects of early growth retardation on adipocyte insulin action. Horm Metab Res 32(2):71–75
Hales CN, Desai M, Ozanne SE, Crowther NJ (1996) Fishing in the stream of diabetes: from measuring insulin to the control of fetal organogenesis. Biochem Soc Trans 24(2):341–350
Strakovsky RS, Zhang X, Zhou D, Pan YX (2011) Gestational high fat diet programs hepatic phosphoenolpyruvate carboxykinase gene expression and histone modification in neonatal offspring rats. J Physiol 589(Pt 11):2707–2717
Wang L, Xu S, Lee JE, Baldridge A, Grullon S, Peng W et al (2013) Histone H3K9 methyltransferase G9a represses PPARgamma expression and adipogenesis. EMBO J 32(1):45–59
Abu-Farha M, Tiss A, Abubaker J, Khadir A, Al-Ghimlas F, Al-Khairi I et al (2013) Proteomics analysis of human obesity reveals the epigenetic factor HDAC4 as a potential target for obesity. PLoS One 8(9):e75342
Gillman MW (2005) Developmental origins of health and disease. N Engl J Med 353(17):1848–1850
Barker DJ (2012) Sir Richard Doll Lecture. Developmental origins of chronic disease. Public Health 126(3):185–189
Swanson JM, Entringer S, Buss C, Wadhwa PD (2009) Developmental origins of health and disease: environmental exposures. Semin Reprod Med 27(5):391–402
Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero? Lancet 335(8695):939–940
Troisi R, Potischman N, Hoover RN (2007) Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 16(9):1700–1712
Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 8(12):1088–1100
Eriksson M, Wedel H, Wallander MA, Krakau I, Hugosson J, Carlsson S et al (2007) The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age. Prostate 67(11):1247–1254
Vatten LJ, Nilsen TI, Tretli S, Trichopoulos D, Romundstad PR (2005) Size at birth and risk of breast cancer: prospective population-based study. Int J Cancer 114(3):461–464
Platz EA, Giovannucci E, Rimm EB, Curhan GC, Spiegelman D, Colditz GA et al (1998) Retrospective analysis of birth weight and prostate cancer in the Health Professionals Follow-up Study. Am J Epidemiol 147(12):1140–1144
Hjalgrim LL, Westergaard T, Rostgaard K, Schmiegelow K, Melbye M, Hjalgrim H et al (2003) Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol 158(8):724–735
Eriksson JG, Thornburg KL, Osmond C, Kajantie E, Barker DJ (2010) The prenatal origins of lung cancer. I. The fetus. Am J Hum Biol 22(4):508–511
Barker DJ, Thornburg KL, Osmond C, Kajantie E, Eriksson JG (2010) The prenatal origins of lung cancer. II. The placenta. Am J Hum Biol 22(4):512–516
Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284(15):878–881
Baird DD, Newbold R (2005) Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol 20(1):81–84
Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W et al (2006) Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15(8):1509–1514
Schrager S, Potter BE (2004) Diethylstilbestrol exposure. Am Fam Physician 69(10):2395–2400
Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G et al (2009) Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiol Biomarkers Prev 18(5):1484–1491
Walker CL, Ho SM (2012) Developmental reprogramming of cancer susceptibility. Nat Rev Cancer 12(7):479–486
De Assis S, Hilakivi-Clarke L (2006) Timing of dietary estrogenic exposures and breast cancer risk. Ann N Y Acad Sci 1089:14–35
Soto AM, Vandenberg LN, Maffini MV, Sonnenschein C (2008) Does breast cancer start in the womb? Basic Clin Pharmacol Toxicol 102(2):125–133
de Assis S, Warri A, Cruz MI, Laja O, Tian Y, Zhang B et al (2012) High-fat or ethinyl-oestradiol intake during pregnancy increases mammary cancer risk in several generations of offspring. Nat Commun 3:1053
Tost J (2009) DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Methods Mol Biol 507:3–20
Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A et al (2010) The NIH roadmap epigenomics mapping consortium. Nat Biotechnol 28(10):1045–1048
Wijetunga NA, Delahaye F, Zhao YM, Golden A, Mar JC, Einstein FH et al (2014) The meta-epigenomic structure of purified human stem cell populations is defined at cis-regulatory sequences. Nat Commun 5:5195
Martin L (1945) The hereditary and familial aspects of exophthalmic goitre and nodular goitre. Q J Med 14:207–219
Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK et al (2007) Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A 104(9):3414–3419
Lambert MP, Paliwal A, Vaissiere T, Chemin I, Zoulim F, Tommasino M et al (2011) Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 54(4):705–715
Lima SC, Hernandez-Vargas H, Herceg Z (2010) Epigenetic signatures in cancer: implications for the control of cancer in the clinic. Curr Opin Mol Ther 12(3):316–324
Wild CP (2005) Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 14(8):1847–1850
Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD et al (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39(3):311–318
Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL et al (2008) Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res 68(8):2661–2670
Yamashita S, Hosoya K, Gyobu K, Takeshima H, Ushijima T (2009) Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis. DNA Res 16(5):275–286
Michels KB, Binder AM, Dedeurwaerder S, Epstein CB, Greally JM, Gut I et al (2013) Recommendations for the design and analysis of epigenome-wide association studies. Nat Methods 10(10):949–955
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Einstein, F.H. (2016). Early Life: Epigenetic Effects on Obesity, Diabetes, and Cancer. In: Berger, N. (eds) Epigenetics, Energy Balance, and Cancer. Energy Balance and Cancer, vol 11. Springer, Cham. https://doi.org/10.1007/978-3-319-41610-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-41610-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41608-3
Online ISBN: 978-3-319-41610-6
eBook Packages: MedicineMedicine (R0)